| Product Code: ETC10074775 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam GLP 1 Receptor Agonist Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam GLP 1 Receptor Agonist Market - Industry Life Cycle |
3.4 Vietnam GLP 1 Receptor Agonist Market - Porter's Five Forces |
3.5 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Vietnam GLP 1 Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Vietnam |
4.2.2 Growing awareness about the benefits of GLP-1 receptor agonists in managing diabetes |
4.2.3 Favorable government initiatives promoting diabetes management and treatment |
4.3 Market Restraints |
4.3.1 High cost associated with GLP-1 receptor agonist medications |
4.3.2 Limited availability and accessibility of advanced diabetes treatments in certain regions of Vietnam |
5 Vietnam GLP 1 Receptor Agonist Market Trends |
6 Vietnam GLP 1 Receptor Agonist Market, By Types |
6.1 Vietnam GLP 1 Receptor Agonist Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Ozempic, 2021- 2031F |
6.1.4 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Trulicity, 2021- 2031F |
6.1.5 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Mounjaro, 2021- 2031F |
6.1.6 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Wegovy, 2021- 2031F |
6.1.7 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Rybelsus, 2021- 2031F |
6.1.8 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Saxenda, 2021- 2031F |
6.2 Vietnam GLP 1 Receptor Agonist Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Type 2 Diabetes Mellitus, 2021- 2031F |
6.2.3 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Obesity, 2021- 2031F |
6.3 Vietnam GLP 1 Receptor Agonist Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.3 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Oral, 2021- 2031F |
6.4 Vietnam GLP 1 Receptor Agonist Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Vietnam GLP 1 Receptor Agonist Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Vietnam GLP 1 Receptor Agonist Market Import-Export Trade Statistics |
7.1 Vietnam GLP 1 Receptor Agonist Market Export to Major Countries |
7.2 Vietnam GLP 1 Receptor Agonist Market Imports from Major Countries |
8 Vietnam GLP 1 Receptor Agonist Market Key Performance Indicators |
8.1 Number of diabetes patients using GLP-1 receptor agonists |
8.2 Adoption rate of GLP-1 receptor agonists among healthcare providers |
8.3 Number of clinical trials or research studies on GLP-1 receptor agonists conducted in Vietnam |
9 Vietnam GLP 1 Receptor Agonist Market - Opportunity Assessment |
9.1 Vietnam GLP 1 Receptor Agonist Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Vietnam GLP 1 Receptor Agonist Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Vietnam GLP 1 Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Vietnam GLP 1 Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Vietnam GLP 1 Receptor Agonist Market - Competitive Landscape |
10.1 Vietnam GLP 1 Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 Vietnam GLP 1 Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here